Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
Raffaele Marfella, Pasquale Paolisso, Celestino Sardu, Luca Bergamaschi, Emanuela Concetta D’Angelo, Michelangela Barbieri, Maria Rosaria Rizzo, Vincenzo Messina, Paolo Maggi, Nicola Coppola, Carmine Pizzi, Mauro Biffi, Pierluigi Viale, Nazzareno Galiè, Giuseppe Paolisso
Topics & Concepts
TocilizumabMedicineInternal medicineDiabetes mellitusPneumoniaType 2 diabetesCoronavirus disease 2019 (COVID-19)Proportional hazards modelDiseaseGastroenterologyInfectious disease (medical specialty)EndocrinologyHyperglycemia and glycemic control in critically ill and hospitalized patientsCOVID-19 Clinical Research StudiesDiabetes and associated disorders